In contrast, non-CDX2-suppressed colon cancers were most commonly of the CMS2 (33.8%) and CMS3 (23.7%) sub-types, less frequently (18.3%) of the CMS4 sub-type, and rarely belonged to CMS1 (Table 4). Here, CDX2 is linked to malignant colon neoplasm.